These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 25877674)
1. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease. El-Matary W; Dupuis K; Sokoro A Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674 [TBL] [Abstract][Full Text] [Related]
2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
3. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease]. Le Goff C; Chapelle JP; Lutteri L Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604 [TBL] [Abstract][Full Text] [Related]
5. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Forcione DG; Rosen MJ; Kisiel JB; Sands BE Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice? Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069 [TBL] [Abstract][Full Text] [Related]
8. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Van Kemseke C; Belaïche J; Steeman C; Louis E Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142 [TBL] [Abstract][Full Text] [Related]
9. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572 [TBL] [Abstract][Full Text] [Related]
10. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease. Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572 [TBL] [Abstract][Full Text] [Related]
11. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Amre DK; Lu SE; Costea F; Seidman EG Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223 [TBL] [Abstract][Full Text] [Related]
12. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988 [TBL] [Abstract][Full Text] [Related]
13. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study. Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542 [No Abstract] [Full Text] [Related]
14. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Sutton CL; Yang H; Li Z; Rotter JI; Targan SR; Braun J Gut; 2000 Jan; 46(1):58-63. PubMed ID: 10601056 [TBL] [Abstract][Full Text] [Related]
15. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population. O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859 [TBL] [Abstract][Full Text] [Related]
17. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471 [TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis. Mankaï A; Thabet Y; Manoubi W; Achour A; Sakly W; Ghedira I Endocr Res; 2013; 38(2):98-104. PubMed ID: 22992126 [TBL] [Abstract][Full Text] [Related]
19. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. Barta Z; Csípõ I; Szabó GG; Szegedi G World J Gastroenterol; 2003 Oct; 9(10):2308-12. PubMed ID: 14562398 [TBL] [Abstract][Full Text] [Related]
20. Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting. Sendid B; Jawhara S; Sarter H; Maboudou P; Thierny C; Gower-Rousseau C; Colombel JF; Poulain D Virulence; 2018; 9(1):1224-1229. PubMed ID: 30027793 [No Abstract] [Full Text] [Related] [Next] [New Search]